Given the stepwise increasing trends of MACC1 and MET expression from benign nevi, to primary to metastatic melanomas, it would also be of interest to examine their expressions in melanomas in situ, which might provide further suggestions on at which cancer development step(s) MACC1 and MET play a role. The gene discussed is MET; the disease is cancer.